human
cathepsin
w
ctsw
cystein
proteas
identifi
genomewid
rna
interfer
rnai
screen
requir
influenza
viru
iav
replic
studi
show
reduc
level
express
ctsw
reduc
viral
titer
differ
subtyp
iav
map
target
step
ctsw
requir
viral
entri
use
set
small
interf
rna
sirna
target
ctsw
demonstr
knockdown
ctsw
result
decreas
iav
nucleoprotein
accumul
nuclei
infect
cell
h
postinfect
assay
specif
individu
stage
iav
entri
show
attach
intern
earli
endosom
traffick
affect
ctsw
knockdown
howev
detect
impair
escap
viral
particl
late
endosom
ctsw
knockdown
cell
moreov
fusion
analysi
duallabel
influenza
viru
reveal
signific
reduct
fusion
event
detect
impact
endosom
ph
suggest
ctsw
requir
stage
viral
fusion
defect
iav
entri
upon
ctsw
knockdown
could
rescu
ectop
express
wildtyp
ctsw
express
catalyt
inact
mutant
ctsw
suggest
proteolyt
activ
ctsw
requir
success
entri
iav
result
establish
ctsw
import
host
factor
entri
iav
target
cell
suggest
ctsw
could
promis
target
develop
futur
antivir
drug
veal
hundr
potenti
cellular
target
howev
limit
knowledg
factor
support
viru
replic
would
requir
drug
develop
character
cathepsin
w
one
candid
factor
found
cathepsin
w
requir
escap
influenza
viru
late
endosom
importantli
requir
proteolyt
activ
cathepsin
w
therefor
suggest
cathepsin
w
could
target
futur
host
celldirect
antivir
therapi
citat
eding
pohl
mo
e
stertz
cathepsin
w
requir
escap
influenza
viru
late
endosom
mbio
cystein
proteas
papain
superfamili
involv
numer
cellular
function
regul
apoptosi
establish
inflammatori
process
ctsw
togeth
cathepsin
f
belong
rel
new
subgroup
flike
cathepsin
distinct
wellstudi
cathepsin
band
llike
subgroup
cathepsin
b
l
shown
requir
ebola
viru
entri
cleav
viral
glycoprotein
endosom
compart
moreov
inhibit
cathepsin
l
also
result
inhibit
sever
acut
respiratori
syndrom
coronaviru
sarscov
infect
wherea
cathepsin
b
implic
entri
nipah
viru
contrast
cathepsin
b
l
noth
known
possibl
function
ctsw
viral
infect
cathepsin
b
l
lysosom
enzym
ctsw
found
local
predominantli
endoplasm
reticulum
er
hela
natur
killer
nk
cell
high
express
cell
nk
cell
upregul
interleukin
also
distinguish
ctsw
member
famili
observ
ctsw
need
effector
function
cell
question
function
ctsw
remain
unansw
use
assay
specif
distinct
stage
iav
entri
show
ctsw
play
role
late
endosom
escap
iav
cystein
proteas
activ
need
function
establish
ctsw
novel
host
factor
entri
iav
potenti
drug
target
human
cathepsin
w
ctsw
among
wellscor
hit
identifi
genomewid
rnai
screen
host
factor
requir
iav
replic
suggest
ctsw
could
play
role
iav
entri
order
confirm
extend
find
analyz
impact
small
interf
rna
sirna
mediat
ctsw
knockdown
viral
growth
iav
strain
differ
time
postinfect
pi
fig
deplet
ctsw
use
two
differ
sirna
sictsw
sictsw
found
reduc
titer
compar
cell
transfect
nontarget
control
sirna
siscr
cell
treat
sirna
target
either
subunit
vacuolar
atpas
sivatpas
viral
nucleoprotein
sinp
show
almost
complet
block
replic
sictswmedi
reduct
viral
titer
limit
cell
observ
similar
effect
lung
fibroblast
cell
fig
check
whether
sictsw
treatment
lead
reduct
viral
titer
multipl
iav
strain
perform
infect
experi
sirnatr
cell
highli
pathogen
avian
strain
human
strain
fig
viral
strain
show
signific
decreas
viral
replic
time
point
test
assess
whether
observ
inhibit
specif
iav
analyz
impact
ctsw
knockdown
replic
vesicular
stomat
viru
vsv
sictsw
treatment
lead
signific
reduct
vsv
titer
h
pi
fig
suggest
requir
ctsw
specif
iav
independ
cell
line
iav
strain
endogen
amount
ctsw
cell
low
detect
western
blot
therefor
test
knockdown
effici
differ
sirna
cotransfect
sirna
plasmid
encod
ctsw
perform
western
blot
analysi
h
transfect
sirna
ctsw
potent
inhibit
ctsw
express
fig
cathepsin
w
requir
earli
step
influenza
viru
replic
next
evalu
requir
ctsw
earli
stage
iav
infect
use
immunofluorescencebas
readout
measur
amount
np
within
cell
nuclei
sirnatransfect
cell
earli
time
point
infect
h
sirna
transfect
cell
infect
multipl
infect
moi
h
pi
np
stain
analyz
confoc
microscopi
control
cell
treat
siscr
cell
nuclei
show
clear
signal
np
wherea
cell
treat
sictsw
sivatpas
control
show
drastic
reduct
nuclear
np
fig
exclud
offtarget
effect
repeat
experi
use
six
differ
sirna
target
ctsw
sirna
np
signal
h
pi
within
cell
nuclei
n
quantifi
observ
strong
decreas
compar
siscrtreat
cell
fig
six
sirna
reduc
plasmidbas
express
ctsw
substanti
fig
suggest
abl
reduc
endogen
level
ctsw
optim
amount
iav
addit
impact
cell
viabil
observ
sirna
target
ctsw
fig
data
indic
ctsw
requir
earli
step
iav
replic
cycl
cathepsin
w
requir
attach
intern
earli
endosom
traffick
iav
character
function
ctsw
iav
replic
test
impact
ctsw
knockdown
initi
step
viral
life
cycl
first
examin
effect
sirnamedi
knockdown
ctsw
viral
attach
intern
use
biotinyl
iav
visual
streptavidin
cell
transfect
respect
sirna
infect
biotinyl
iav
min
ice
allow
attach
prevent
intern
fix
stain
streptavidin
flow
cytometr
analysi
membranebound
viru
reveal
differ
percentag
cell
siscror
sictswtreat
cell
fig
sampl
label
min
indic
viral
attach
affect
ctsw
knockdown
signal
strongli
reduc
cell
preincub
unlabel
streptavidin
fixat
stain
fig
sampl
label
min
strep
show
specif
stain
membranebound
viru
block
unlabel
streptavidin
second
set
sampl
transfer
infect
ice
allow
intern
viru
min
incub
cell
either
mock
treat
incub
unlabel
streptavidin
fix
stain
streptavidin
pretreat
streptavidin
could
partial
block
signal
intern
viru
particl
protect
unlabel
streptavidin
fig
sampl
label
min
strep
therefor
ratio
block
unblock
label
indic
amount
intern
viru
attach
signific
differ
cell
transfect
siscr
sictsw
fig
bottom
right
graph
data
indic
ctsw
requir
attach
intern
iav
attach
intern
viru
transport
via
endosom
pathway
cytoplasm
endosom
differenti
use
set
molecular
marker
earli
endosom
antigen
specif
marker
earli
endosom
elucid
whether
ctsw
play
role
earli
eding
et
al
endosom
traffick
transfect
cell
control
sirna
sirna
target
ctsw
infect
cell
moi
viral
infect
synchron
cold
bind
step
h
cold
bind
step
inoculum
remov
temperatur
shift
cell
fix
differ
time
point
min
pi
quantifi
amount
viral
np
earli
endosom
perform
immunofluoresc
analysi
np
measur
percentag
np
coloc
use
imari
softwar
min
pi
differ
coloc
np
earli
endosom
marker
observ
siscror
sictswtreat
cell
fig
within
first
min
pi
rapid
increas
coloc
np
detect
coloc
declin
indic
transient
presenc
viral
particl
within
earli
endosom
compart
repres
imag
time
point
illustr
observ
coloc
siscrand
sictswtreat
cell
fig
see
fig
supplement
materi
suggest
ctsw
requir
earli
endosom
traffick
presum
later
step
affect
ctsw
knockdown
cathepsin
w
requir
late
endosom
escap
influenza
viru
follow
endosom
pathway
viral
particl
transport
earli
late
endosom
encount
low
ph
requir
fusion
test
whether
ctsw
requir
traffick
late
endosom
transfect
cell
sirna
target
ctsw
nontarget
control
sirna
infect
cell
moi
initi
cold
bind
step
h
temperatur
shift
allow
viru
entri
incub
stop
min
pi
cell
stain
np
late
endosom
marker
lysobisphosphatid
acid
lbpa
quantifi
percentag
np
coloc
lbpa
use
imari
softwar
expect
siscrtreat
cell
coloc
np
lbpa
observ
min
pi
fig
note
observ
coloc
less
pronounc
earli
endosom
marker
indic
rapid
transport
late
endosom
compart
min
pi
np
longer
coloc
lbpa
control
cell
time
np
abundantli
present
within
nuclei
infect
cell
fig
top
row
see
fig
supplement
materi
contrast
cell
treat
sictsw
display
extend
coloc
np
lbpa
observ
major
np
signal
remain
trap
lbpaposit
compart
instead
traffick
nucleu
shown
repres
imag
pi
time
point
fig
bottom
row
fig
confirm
ctsw
requir
incom
virion
repeat
experi
presenc
cycloheximid
block
translat
thu
synthesi
new
np
min
pi
observ
equal
amount
np
coloc
lbpa
siscrtransfect
control
cell
sictswtransfect
cell
fig
contrast
min
min
pi
detect
np
lbpaposit
compart
sictswtransfect
cell
wherea
nuclear
np
becam
detect
control
cell
fig
see
fig
supplement
materi
taken
togeth
result
suggest
ctsw
requir
escap
iav
late
endosom
andor
transport
rnp
nucleu
distinguish
two
possibl
next
test
whether
fusion
viral
endosom
membran
still
occur
absenc
ctsw
gener
duallabel
viru
allow
us
measur
fusion
quantit
manner
iav
particl
label
two
differ
dye
one
dye
octadecyl
rhodamin
b
chlorid
red
quench
fluoresc
dye
dioc
oxacarbocyanin
green
membran
fusion
occur
dioc
diffus
endosom
membran
quench
longer
possibl
enabl
detect
dioc
fluoresc
infect
sirnatransfect
cell
either
pretreat
dimethyl
sulfoxid
dmso
bafilomycin
known
inhibitor
endosom
acidif
viral
fusion
synchron
infect
ad
viru
initi
cold
bind
step
temperatur
shift
allow
viral
entri
fusion
min
min
pi
cell
analyz
confoc
microscopi
fusion
site
visibl
bright
green
spot
dioc
fluoresc
fusion
site
white
arrowhead
fig
predominantli
visibl
siscrtransfect
control
cell
pretreat
dmso
sictswand
sivatpasetransfect
cell
display
fewer
fusion
site
shown
repres
imag
fig
quantifi
number
fusion
site
use
spot
detect
algorithm
imagej
normal
number
cell
nuclei
fig
observ
two
six
fusion
site
per
cell
min
pi
siscrtransfect
cell
pretreat
dmso
contrast
fusion
site
detect
siscrtransfect
cell
pretreat
bafilomycin
also
sictswand
sivatpasetransfect
cell
fusion
site
observ
independ
pretreat
dmso
bafi
lomycin
indic
knockdown
ctsw
result
inhibit
viral
endosom
membran
fusion
sictswmedi
inhibit
fusion
late
endosom
rais
question
whether
ctsw
local
late
endosom
compart
although
previou
studi
report
er
local
ctsw
product
inact
precursor
er
could
mask
presenc
compart
first
analyz
local
ctsw
costain
ctsw
erresid
chaperon
calnexin
cell
stabli
express
ctsw
expect
larg
amount
ctsw
coloc
er
marker
fig
top
panel
unfortun
abl
costain
ctsw
late
endosom
marker
lbpa
antibodi
deriv
mice
therefor
costain
marker
late
endosom
observ
consider
amount
coloc
fig
bottom
panel
thu
cell
ctsw
local
er
also
least
partial
late
endosom
could
function
enabl
iav
fusion
cathepsin
w
requir
acidif
endosom
anoth
late
fuse
viru
next
test
whether
inhibit
viral
fusion
upon
knockdown
ctsw
due
chang
ph
endosom
possibl
impact
acidif
aim
treat
sirnatransfect
cell
lysotrack
ly
dye
stain
acid
compart
red
fluoresc
expect
cell
treat
vatpas
inhibitor
bafilomycin
display
lysotrack
signal
fig
bottom
row
cell
transfect
sictsw
still
display
strong
lysotrack
stain
indistinguish
control
cell
fig
top
row
suggest
knockdown
ctsw
drastic
alter
endosom
ph
therebi
inhibit
fusion
howev
still
possibl
minor
chang
ph
detect
lysotrack
dye
could
contribut
observ
effect
therefor
test
impact
ctsw
knockdown
strain
iav
recent
shown
higher
ph
fusion
optimum
ph
compar
ph
reduc
level
ctsw
result
slightli
increas
endosom
ph
viru
strain
display
reduc
sensit
knockdown
ctsw
transfect
cell
control
ctswtarget
sirna
infect
cell
viru
moi
quantifi
nuclear
np
observ
replic
slowli
nuclear
np
detect
h
pi
onward
data
shown
therefor
chose
time
point
quantifi
nuclear
np
similar
result
obtain
detect
strong
reduct
nuclear
np
accumul
upon
knockdown
ctsw
fig
see
fig
supplement
materi
next
test
impact
ctsw
knockdown
lymphocyt
choriomening
viru
lcmv
also
fuse
acid
compart
cell
transfect
control
siscr
display
robust
viral
replic
cytoplasm
infect
cell
fig
fig
wherea
lower
level
viral
np
detect
cell
transfect
sivatpas
cell
transfect
two
sirna
target
ctsw
could
detect
signific
chang
cytoplasm
replic
lcmv
therefor
conclud
although
lcmv
late
fuse
viru
depend
ctsw
fusion
data
suggest
ctsw
impact
endosom
ph
yet
requir
viral
endosom
fusion
iav
lcmv
cathepsin
w
cleav
viral
glycoprotein
given
cathepsin
famili
member
shown
proteolyt
process
viral
glycoprotein
next
test
whether
ctsw
cleav
iav
protein
incom
virion
sinc
previou
experi
perform
stock
iav
grown
presenc
trypsin
thu
contain
neglig
level
fig
expect
find
role
ctsw
cleavag
howev
addit
cleavag
event
hemagglutinin
ha
neuraminidas
na
could
possibl
infect
control
cell
cell
overexpress
ctsw
moi
h
h
cell
lysat
prepar
test
viral
protein
level
ctsw
express
sinc
map
target
step
ctsw
event
fusion
late
endosom
expect
np
matrix
protein
proteolyt
process
ctsw
inde
level
np
unchang
upon
overexpress
ctsw
lowermolecularmass
band
observ
fig
see
fig
supplement
materi
interestingli
also
found
similar
level
two
viral
surfac
glycoprotein
ha
na
fig
fig
could
detect
cleavag
product
lower
molecular
mass
either
protein
thu
assum
ctswdepend
cleavag
viral
surfac
glycoprotein
take
place
enzymat
activ
cathepsin
w
requir
influenza
viru
entri
test
whether
catalyt
activ
cystein
proteas
requir
function
ctsw
iav
entri
gener
enzymat
inact
mutant
ctsw
ctsw
replac
cystein
posit
part
catalyt
triad
alanin
addit
introduc
three
silent
mutat
achiev
resist
one
sirna
ctsw
wildtyp
ctswand
ctsw
encod
construct
construct
clone
lentivir
vector
use
gener
stabl
cell
line
express
either
ctsw
ctswre
ctsw
addit
cell
transduc
lentiviru
carri
insert
control
cell
valid
cell
line
transfect
either
sirna
target
ctsw
control
siscr
lysat
analyz
western
blot
ctsw
express
describ
endogen
level
ctsw
detect
contrast
cell
line
transduc
express
either
wildtyp
ctsw
ctsw
show
robust
express
ctsw
transfect
siscr
sictsw
construct
made
resist
fig
expect
sictsw
still
abl
reduc
ctsw
level
limit
detect
western
blot
valid
gener
cell
line
addit
also
assess
growth
iav
cell
line
overexpress
either
wild
type
mutant
ctsw
found
differ
iav
replic
see
fig
supplement
materi
next
made
use
cell
line
assess
whether
catalyt
activ
ctsw
requir
function
iav
entri
transfect
ctswtarget
control
sirna
infect
cell
moi
initi
cold
bind
step
allow
infect
proceed
h
stain
iav
np
measur
np
signal
within
nuclei
infect
cell
three
cell
line
transfect
siscr
show
clear
np
signal
nucleu
h
pi
fig
expect
nuclear
np
signal
strongli
reduc
control
cell
upon
knockdown
ctsw
either
two
sirna
fig
top
row
contrast
ctswre
cell
transfect
sictsw
display
significantli
higher
np
signal
due
overexpress
sirnaresist
ctsw
effect
specif
sictsw
transfect
sictsw
still
result
strongli
reduc
nuclear
np
signal
fig
middl
row
could
observ
rescu
infect
sictsw
cell
cell
overexpress
catalyt
inact
ctsw
fig
bottom
row
addit
transfect
cell
line
sirna
target
vatpas
subunit
transduc
cell
transfect
sirna
show
infect
show
observ
rescu
infect
specif
ctsw
knockdown
verifi
find
quantifi
amount
nuclear
np
use
imagej
softwar
sictsw
rescu
infect
wildtyp
ctsw
highli
signific
compar
control
cell
express
inact
mutant
increas
level
nuclear
np
significantli
fig
stain
cell
line
ctswre
ctsw
re
ctsw
immunofluoresc
observ
cell
posit
data
shown
hypothes
could
reason
incomplet
rescu
infect
wildtyp
ctsw
inde
repeat
experi
stain
ctsw
np
parallel
quantifi
nuclear
np
ctswposit
cell
observ
almost
complet
rescu
nuclear
np
fig
taken
togeth
overexpress
ctsw
rescu
effect
sirnamedi
knockdown
ctsw
show
observ
impact
iav
entri
caus
deplet
ctsw
level
rather
offtarget
effect
sirna
moreov
proteolyt
activ
ctsw
requir
role
escap
iav
late
endosom
min
ice
transfer
min
lyse
viral
protein
level
analyz
western
blot
use
antibodi
ha
na
np
ctsw
gapdh
load
control
asterisk
mark
np
band
visibl
na
band
blot
first
stain
np
subsequ
na
panel
e
result
one
experi
repres
least
two
independ
experi
shown
genomewid
rnai
screen
discov
plethora
cellular
factor
influenza
virus
hijack
replic
list
identifi
factor
hold
great
potenti
reveal
new
aspect
virushost
interplay
therebi
uncov
novel
detail
cellular
process
moreov
requir
cellular
protein
repres
potenti
drug
target
shown
et
al
stertz
shaw
howev
date
littl
followup
identifi
factor
far
promis
drug
target
emerg
screen
studi
character
ctsw
one
hit
identifi
genomewid
rnai
screen
show
ctsw
requir
fusion
influenza
viru
endosom
membran
subsequ
escap
iav
cytoplasm
provir
function
ctsw
requir
catalyt
activ
therefor
suggest
ctsw
could
potenti
drug
target
worth
explor
develop
novel
antivir
agent
data
show
knockdown
ctsw
sirna
lead
reduc
viru
titer
number
differ
strain
iav
fig
due
offtarget
effect
sirna
sinc
six
differ
sirna
ctsw
result
phenotyp
fig
reintroduct
ctsw
express
rescu
inhibit
iav
fig
data
suggest
specif
role
ctsw
compens
cathepsin
line
hypothesi
detect
inhibit
iav
inhibitor
cathepsin
l
cathepsin
b
data
shown
map
step
viral
replic
cycl
requir
ctsw
found
h
pi
amount
nuclear
np
alreadi
strongli
decreas
upon
ctsw
knockdown
fig
finer
map
target
step
reveal
viru
attach
intern
earli
endosom
traffick
affect
howev
escap
iav
late
endosom
block
viral
fusion
strongli
inhibit
upon
ctsw
knockdown
fig
therefor
conclud
ctsw
requir
fusion
step
fusion
event
detail
understand
function
viral
protein
fusion
event
littl
known
cellular
player
involv
earli
observ
low
ph
requir
fusion
endosom
vatpas
complex
need
cell
transduc
use
lentivir
system
gener
stabl
cell
line
express
wildtyp
ctsw
ctswre
mutant
ctsw
made
resist
sictsw
introduct
three
silent
mutat
target
site
sictsw
cell
transduc
lentiviru
carri
insert
use
control
con
cell
transfect
sirna
indic
ctsw
express
assess
western
blot
use
mous
monoclon
antibodi
ctsw
antibodi
gapdh
load
control
b
c
control
cell
cell
stabli
express
ctsw
wild
type
mutant
transfect
sirna
target
ctsw
nontarget
control
h
posttransfect
cell
infect
moi
h
cell
stain
use
mous
monoclon
antinp
antibodi
plu
secondari
antibodi
antimous
dapi
repres
imag
shown
panel
b
bar
c
nuclear
np
quantifi
use
imagej
softwar
signific
test
twotail
student
test
perform
n
valu
significantli
differ
indic
bar
asterisk
follow
p
valu
significantli
differ
p
indic
ns
experiment
setup
describ
panel
b
stain
perform
use
rabbit
polyclon
serum
np
mous
monoclon
antibodi
ctsw
quantif
nuclear
np
cell
express
ctsw
includ
analysi
signific
test
twotail
student
test
perform
n
panel
result
one
experi
repres
three
independ
experi
shown
provid
lowph
environ
endosom
recent
tetraspanin
identifi
second
cellular
player
fusion
process
far
understand
exert
function
studi
identifi
novel
player
fusion
process
ctsw
analyz
subcellular
local
ctsw
found
signific
fraction
ctsw
stain
coloc
erresid
chaperon
calnexin
fig
consist
previou
find
report
er
local
ctsw
interestingli
also
detect
coloc
late
endosom
marker
fig
therefor
assum
least
fraction
ctsw
local
late
endosom
would
consist
function
ctsw
viral
fusion
process
take
place
late
endosom
notabl
detect
two
easili
separ
band
ctsw
western
blot
top
band
could
sometim
observ
doublet
contrast
singl
band
could
detect
catalyt
inact
mutant
thu
far
specul
addit
band
repres
modifi
form
requir
studi
result
obtain
catalyt
inact
mutant
fig
hypothes
ctsw
cleav
yet
unknown
target
late
endosom
proteolyt
cleavag
event
import
fusion
viral
endosom
membran
proteolyt
cleavag
event
seem
impact
endosom
ph
first
knockdown
ctsw
result
detect
chang
lysotrack
signal
mark
acid
organel
fig
second
strain
iav
shown
higher
ph
optimum
fusion
ph
versu
ph
inhibit
knockdown
ctsw
extent
similar
strain
fig
instead
hypothes
low
ph
rather
requir
ctsw
function
shown
cathepsin
famili
member
substrat
cleav
ctsw
enabl
fusion
occur
yet
identifi
use
trypsintr
viru
stock
experi
expect
find
role
ctsw
ha
cleavag
ha
ha
ha
moreov
strain
contain
multibas
cleavag
site
ha
protein
also
sensit
ctsw
knockdown
fig
therefor
specul
addit
cleavag
event
could
occur
ha
na
experi
aim
detect
cleavag
event
earli
stage
viral
entri
show
differ
control
cell
cell
overexpress
ctsw
fig
could
indic
cellular
protein
cleav
degrad
ctsw
rather
viral
protein
howev
exclud
possibl
small
fraction
viral
protein
target
ctsw
detect
western
blot
set
summari
studi
establish
ctsw
novel
cellular
factor
requir
entri
iav
target
cell
stage
fusion
viral
endosom
membran
proteolyt
activ
ctsw
need
provir
function
therebi
present
potenti
drug
target
futur
develop
new
antivir
influenza
plasmid
antibodi
express
construct
pcaggsctsw
gener
pcr
amplifi
cdna
ctsw
plasmid
cmv
stand
cytomegaloviru
catalog
origen
use
forward
primer
revers
primer
clone
pcagg
use
ecori
xhoi
plasmid
pcaggsflagctsw
construct
way
use
differ
forward
primer
next
three
silent
mutat
introduc
cdna
ctsw
make
resist
knock
sictsw
use
quikchang
mutagenesi
kit
agil
technolog
follow
primer
forward
revers
catalyt
inact
mutant
ctsw
also
gener
use
quikchang
mutagenesi
kit
follow
primer
forward
revers
cdna
ctsw
sire
ctsw
sire
amplifi
pcr
use
forward
primer
revers
primer
cdna
clone
lentivir
vector
plvxirespuro
ire
stand
intern
ribosom
entri
site
puro
stand
puromycin
catalog
clontech
ecori
xbai
result
construct
plvxctsw
sire
irespuro
plvxctsw
sire
irespuro
verifi
sequenc
western
blot
immunofluoresc
follow
primari
antibodi
use
mous
monoclon
ctsw
antibodi
catalog
sigmaaldrich
horseradish
peroxidas
hrp
conjug
dehydrogenas
gapdh
antibodi
hrp
conjug
santa
cruz
mous
monoclon
antibodi
atcc
rabbit
polyclon
np
antibodi
western
blot
kind
gift
nieto
centro
nacion
de
madrid
spain
rabbit
polyclon
np
antibodi
immunofluoresc
kind
gift
p
pales
mount
sinai
hospit
ny
usa
mous
monoclon
ha
antibodi
rabbit
polyclon
na
antibodi
catalog
thermo
scientif
mous
monoclon
antibodi
catalog
bd
bioscienc
mous
monoclon
lbpa
also
call
bi
monoacylglyceryl
phosphat
bmp
antibodi
catalog
zplbpa
echelon
bioscienc
mous
monoclon
lcmv
np
antibodi
kindli
provid
kunz
univers
hospit
lausann
lausann
switzerland
rabbit
polyclon
calnexin
antibodi
catalog
abcam
rabbit
polyclon
antibodi
abcam
rabbit
polyclon
flag
antibodi
abcam
western
blot
analysi
western
blot
analysi
cell
lyse
use
laemmli
buffer
mm
trishcl
ph
glycerol
sd
mm
dithiothreitol
dtt
bromophenol
blue
lysat
run
gel
protein
transfer
hybond
ecl
nitrocellulos
membran
fisher
scientif
follow
transfer
membran
block
use
milk
powder
trisbuff
salin
tb
supplement
tween
tbst
primari
secondari
antibodi
dilut
tbst
milk
powder
incub
membran
room
temperatur
rt
h
enhanc
chemiluminesc
ecl
substrat
thermo
scientif
use
detect
protein
band
dna
sirna
transfect
sirna
purchas
qiagen
transfect
use
lipofectamin
rnaimax
catalog
life
technolog
cell
revers
transfect
sirna
accord
manufactur
protocol
final
concentr
sirna
nm
h
transfect
effici
control
cell
death
cell
cell
viabil
monitor
use
celltiterglo
luminesc
cell
viabil
assay
catalog
promega
plasmid
transfect
perform
use
jetprim
catalog
polyplu
accord
manufactur
protocol
plasmidsirna
cotransfect
perform
use
lipofectamin
life
technolog
instruct
manufactur
sirna
sequenc
sirna
qiagen
order
dtdt
overhang
store
sequenc
sirna
follow
qiagen
catalog
number
shown
parenthes
custom
sirna
sictsw
sictsw
sictsw
sictsw
sictsw
sictsw
sinp
custom
sirna
viru
infect
titrat
viru
infect
cell
phosphatebuff
salin
pb
supplement
mm
mg
mm
ca
bovin
serum
albumin
bsa
penicillinstreptomycin
use
dilut
viru
stock
cell
wash
prior
infect
inoculum
either
ad
room
temperatur
ice
min
synchron
infect
inoculum
remov
replac
appropri
amount
postinfect
medium
dmem
supplement
bsa
mm
hepe
penicillinstreptomycin
cell
incub
indic
time
infecti
titer
sampl
determin
plaqu
assay
mdck
cell
infect
cell
serial
dilut
sampl
subsequ
immunofluoresc
stain
viral
np
quantifi
infecti
viru
immunofluoresc
stain
microscopi
immunofluoresc
stain
cell
grown
glass
coverslip
plate
cell
fix
paraformaldehyd
pfa
permeabil
use
immunofluoresc
buffer
pb
supplement
mm
nh
cl
saponin
bsa
h
buffer
cell
incub
h
rt
overnight
primari
antibodi
cell
incub
primari
antibodi
wash
three
time
buffer
secondari
antibodi
ad
h
rt
alexa
fluorconjug
donkey
antimouserabbit
antibodi
catalog
life
technolog
use
secondari
antibodi
cell
wash
three
time
buffer
coverslip
dip
deioniz
water
invers
mount
onto
glass
microscop
slide
use
dapi
fluoromount
g
catalog
southern
biotech
microscopi
imag
acquir
confoc
laser
scan
microscop
leica
coloc
analysi
imari
softwar
standard
coloc
set
use
imag
process
quantif
nuclear
np
signal
well
fusion
site
analysi
perform
use
imagej
softwar
statist
analysi
done
use
prism
softwar
attach
intern
assay
attach
intern
assay
perform
previous
describ
briefli
concentr
sucros
cushion
biotinyl
use
ezlink
nhsss
biotin
kit
thermo
scientif
sirnatransfect
cell
detach
cool
ice
fluorescenceactiv
cell
sort
fac
buffer
pb
supplement
bsa
cell
infect
ice
biotinyl
h
wash
thoroughli
fac
buffer
cell
incub
min
incub
ice
either
fac
buffer
contain
unconjug
streptavidin
mgml
life
technolog
fac
buffer
alon
follow
intern
cell
either
directli
fix
pfa
incub
fac
buffer
supplement
streptavidin
sodium
azid
min
fix
stain
streptavidin
life
technolog
dilut
fac
buffer
use
fac
analysi
perform
cyan
adp
analyz
beckmann
coulter
inc
data
analyz
use
flowjo
softwar
fusion
assay
measur
viral
fusion
perform
accord
protocol
previous
describ
briefli
iav
label
use
two
fluoresc
dye
octadecyl
rhodamin
b
chlorid
oxacarbocyanin
life
technolog
ratio
final
concentr
intens
vortex
min
rt
label
viru
filter
filter
viru
bound
cell
min
cold
temperatur
cell
wash
pb
temperatur
shift
min
unfix
unpermeabil
sampl
mount
imag
analysi
carri
use
spot
analysi
function
imagej
stain
distinct
spot
size
pixel
subsequ
correct
cell
number
lysotrack
lysotrack
red
catalog
life
technolog
dilut
dmem
growth
medium
ad
cell
final
concentr
nm
cell
incub
min
wash
medium
mount
without
fixat
permeabil
lentiviru
product
transduct
cell
produc
lentivir
particl
cell
transfect
plvxctsw
sire
ire
puro
wild
type
mutant
plasmid
encod
vsv
g
protein
vsvg
express
plasmid
hiv
gagpol
use
fugen
hd
transfect
reagent
promega
supernat
contain
lentivir
particl
harvest
h
transfect
supplement
polybren
final
concentr
gml
transduct
cell
seed
low
densiti
infect
lentivir
particl
kept
h
medium
chang
dmem
growth
medium
ngml
puromycin
select
maintain
subsequ
cultur
supplement
materi
articl
may
found
http
mbioasmorg
figur
tif
file
mb
figur
tif
file
mb
figur
tif
file
mb
